Kestra Investment Management LLC Makes New Investment in Humana Inc. (NYSE:HUM)

Kestra Investment Management LLC acquired a new position in Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 194 shares of the insurance provider’s stock, valued at approximately $49,000.

Other large investors have also recently bought and sold shares of the company. FNY Investment Advisers LLC raised its position in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama raised its position in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares in the last quarter. PDT Partners LLC grew its holdings in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Secure Asset Management LLC acquired a new stake in Humana in the fourth quarter valued at $244,000. Finally, Ontario Teachers Pension Plan Board grew its holdings in Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after purchasing an additional 71,910 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on HUM shares. Truist Financial upped their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Wells Fargo & Company lowered their target price on Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Barclays upped their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Finally, Bank of America raised Humana from an “underperform” rating to a “neutral” rating and upped their target price for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and an average price target of $285.68.

Humana Stock Down 5.7 %

Shares of NYSE:HUM opened at $255.77 on Friday. The stock’s 50-day moving average price is $269.41 and its two-hundred day moving average price is $290.45. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The firm has a market cap of $30.80 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.00 and a beta of 0.56.

Humana (NYSE:HUM) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.38%. Humana’s dividend payout ratio (DPR) is 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.